Kymera IPO Presentation Deck

KYMERA Targeted Protein Degradation Next Potential Breakthrough Modality to Expand Drugged Proteome Human Proteome Targeted Protein Degradation 2020 KYMERA THERAPEUTICK, INC Un-Drugged Opportunity Drugged Undruggable Targets Scaffold, transcript factor, multiple funct Efficient Development / Manufacturing Systemic Exposure Oral Bioavailability Traditional Small Molecule Existing Modalities X X Antibody X #4 BB Antisense ✔ RNAI Cell/Gene Therapy

View entire presentation